Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer. - Gouda MA; Gonugunta A; Dumbrava EE; Yap TA; Rodon J; Piha-Paul SA; Pohlmann PR; Damodaran S; Murthy R; Valero V; Mouabbi JA; Tripathy D; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2025)